CEO designate announcement
Emma Walmsley appointed CEO designate at GSK
On Tuesday 20 September 2016, GSK announced that Emma Walmsley, currently Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division, had been appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017. Emma will join the GSK Board of Directors from 1 January 2017.
How our consumer strategy is improving quality of life and access to established medicines through innovation